News Ripple’s XRP surges to 2024 high amid Trump win, stablecoin optimism Dec 02, 2024 byEzra Reguerra Donald Trump’s election victory, an anticipated conclusion to the SEC lawsuit and an expected stablecoin project may have contributed to the XRP price surge. ...
The SEC’s actions on Ripple began in December 2020 when the commission filed a lawsuit against Garlinghouse, Larsen, and the company largely over sales of its XRP tokens, which the commission also claimed were securities. In July, a federal judgeruled that XRPwas not a security when sold to...
Ripple has been in headlines lately, and not for good news. Apparently, the blockchain company has been sued by the US SEC. When this news broke, many wanted to know why the company didn’t take prior measures to avoid the now very publicized lawsuit. Ripple’s CEO took...
the ongoing SEC vs Ripple dispute has further dampened XRP’s value, with the price dropping approximately 44% since the ruling on July 13, 2023. The possibility of SEC’s appeal, in the absence of a settlement, has further intensified ...
However, this will depend heavily on the final outcome of the SEC vs Ripple lawsuit. You can view an XRP price prediction at on our dedicated price prediction page. The exchange predicts that the price for the crypto will increase gradually over time as more people adopt the new technology....
In a significant development in the ongoing legal battle between the U.S. Securities and Exchange Commission (SEC) and blockchain company Ripple Labs, the SEC
sues Ripple in relation to a specific legal agreement where the firm had agreed to sell up to 5 billion XRP for a certain price. In return, Ripple countersues R3 stating that the company had reneged on a number of contractual promises, and the lawsuit was a ploy to cash in on XRPs in...
Ripple added that the instances cited by the SEC are “inapposite” as the rationale behind amicus briefs is to “aid the court and offer insights not available from the parties (involved in the lawsuit).” “The SEC has sought summary judgment based on what it erroneously claims are undispu...
The lowest court's recent ruling favoring Medytox in a civil lawsuit against Daewoong Pharmaceutical regarding the source of the latter's botulinum toxin (BTX) strain is causing ripples across the botulinum toxin (BTX) industry.Daewoong and its foreign B
“From a platform perspective, xRapid and XRP as an asset is absolutely the best one to use for settlement, We have the liquidity and not the speed and Ripple has the speed so it’s a perfect partnership” xRapid is a decentralized financial tool powered by Ripple’s XRP to enable f...